HighTower Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

HighTower Advisors’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,034	Closed	-$364K	–	3630
2022 Q3	$364K	Buy	+7,034	New	+$291K	﹤0.01%	2227
2022 Q2	–	Sell	-13,161	Closed	-$334K	–	3646
2022 Q1	$334K	Buy	13,161 +5,835	+80%	+$164K	﹤0.01%	2444
2021 Q4	$266K	Buy	+7,326	New	+$257K	﹤0.01%	2553
2021 Q3	–	Sell	-10,523	Closed	-$141K	–	3519
2021 Q2	$141K	Buy	10,523 +3,482	+49%	+$85.8K	﹤0.01%	2737
2021 Q1	$361K	Sell	7,041 -1,800	-20%	-$108K	﹤0.01%	2167
2020 Q4	$547K	Buy	8,841 +41	+0.5%	+$2.35K	﹤0.01%	1596
2020 Q3	$482K	Hold	8,800	–	–	﹤0.01%	1590
2020 Q2	$506K	Hold	8,800	–	–	﹤0.01%	1450
2020 Q1	$354K	Sell	8,800 -75	-0.8%	-$3.19K	﹤0.01%	1483
2019 Q4	$351K	Buy	+8,875	New	+$156K	﹤0.01%	1626

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HighTower Advisors's CCXI Position: Q4 2022 in Review

HighTower Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 7,034 shares — an estimated $364K sold.

HighTower Advisors first reported a position in CCXI in Q4 2019 and held it in 10 quarters. The position peaked at $547K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

HighTower Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
HighTower Advisors sold 7,034 ChemoCentryx, Inc. shares in Q4 2022, an estimated $364K.
HighTower Advisors first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 10 quarters.
HighTower Advisors's ChemoCentryx, Inc. position peaked at $547K in Q4 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on HighTower Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.